More articles from Research Watch

Cemiplimab Achieves Responses in Cutaneous Squamous Cell Carcinoma
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-100
Master Regulators May Be Therapeutic Targets for Precision Oncology
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-107
Mitophagy in Gut Epithelial Cells Promotes Antitumor Immunity
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-104
AR Enhancer Amplification Drives Castration-Resistant Prostate Cancer
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-105
An OXPHOS Inhibitor Has Antitumor Activity in Multiple Tumor Models
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-106
IL1 Blockade May Ameliorate Cytokine Release Syndrome
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-102
BAI1 Stabilizes p53 to Suppress Medulloblastoma Tumorigenesis
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-103
Autologous T Cells Targeting Four Neoantigens Induce Tumor Regression
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-101
The lncRNA ARLNC1 Promotes Prostate Tumorigenesis
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-099
TET2 Disruption Enhances the Efficacy of CD19 CAR T-cell Therapy
Cancer Discovery Jun 2018, DOI: 10.1158/2159-8290.CD-RW2018-098

Main menu